Global Oncology Biosimilars Market 2016-2020

  • Published: Feb 2016
  • Pages: 107
  • SKU: IRTNTR8749

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted

  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

This global market research presents a detailed segmentation of the global oncology biosimilars market by end-user (retail pharmacies and hospitals), by application (cancer treatment drugs and supportive care drugs), and by geography (Americas, APAC, and EMEA). The leading vendors in this market are Biocon, Celltrion, Dr Reddys Laboratories, F Hoffmann-La Roche, Hospira, Mylan, and Sandoz.

Outlook of the global oncology biosimilars market

The global oncology biosimilars market will witness significant growth over the forecast period and is anticipated to grow at an impressive CAGR of around 31% during the forecast period. The growing need for cost-effective treatment methodologies will aid in the steady growth of this market during the forecast period. The high cost of branded biologic oncological drugs will compel patients to shift toward biosimilars as they are highly cost-effective. Since biosimilars cost 10%-30% lower than their parent counterparts, there is the presence of unmet medical needs for such products. This enables domestic manufacturers to market generic versions of the biologic compounds at a lower price, which in turn results in market growth.

Technavio’s market research analyst has estimated factors like the advent of new biosimilars to impel market growth during the forecast period. Unlike generic drugs, which have APIs that are identical to original drugs, biosimilars are similar to their originator biologic compounds. Biosimilars developed by different manufacturers differ from the original product as well as from each other. Since they are less expensive than biologics, patients will be able to afford and access biosimilars more easily than biologics.

End-user segmentation of the oncology biosimilars market

  • Retail pharmacies
  • Hospitals

At present, the retail pharmacies segment dominates this market and accounts for a market share of approximately 52%. Retail pharmacies provide a broad customer base for biosimilar drugs. The widespread availability of biosimilars in retail pharmacies for use in the hospital setting will help in the growth of this market segment during the forecast period.

Geographical segmentation of the oncology biosimilars market

  • Americas
  • APAC
  • EMEA

In terms of geography, the EMEA region will be the largest market for oncology biosimilars during the forecast period. The market in this region will grow profoundly at a CAGR of over 31% and the prospects for market growth in this region will be driven by factors like the presence of well-defined regulatory guidelines, increasing geriatric population, and the patent expiries of biologics. Also, the presence of a strong generic culture in this region will spur the prospects for market growth until the end of 2020.

Competitive landscape and key vendors

The global oncology biosimilars market will have tremendous potential for growth during the forecast period. However, the high costs involved in developing and launching biosimilar products is expected to limit the number of players entering into this market. In this market, the companies range in size from small start-ups to major biopharmaceutical manufacturers.

Key vendors in this market are -

  • Biocon
  • Celltrion
  • Dr Reddy's Laboratories
  • F Hoffmann-La Roche
  • Hospira
  • Mylan
  • Sandoz

Other prominent vendors analysed in this market study are AbbVie, Allergan, Amgen, AstraZeneca, Baxter, Biogen, BioXpress Therapeutics, Boehringer Ingelheim, Cipla, Coherus BioSciences, Coherus BioSciences, Daiichi Sankyo, Emcure Pharmaceuticals, GlaxoSmithKline (GSK), Intas Pharmaceuticals, Merck, Pfizer, Sanofi, 3SBio, and Wockhardt.

Key questions answered in the report include

  • What will the oncology biosimilars size and the growth rate be in 2020?
  • What are the key factors driving the global oncology biosimilars market?
  • What are the key oncology biosimilars trends impacting the growth of the market?
  • What are the challenges to market growth?
  • Who are the key vendors in the global oncology biosimilars market?
  • What are the market opportunities and threats faced by the vendors in the global oncology biosimilars market?
  • What are the trending factors affecting the market shares of the Americas, APAC, and EMEA?
  • What are the key outcomes of the five forces analysis of the global oncology biosimilars market?

Technavio also offers customization on reports based on specific client requirement.

Related reports

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of  the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Overview of cancer

  • Epidemiology
  • Economic burden of cancer

PART 06: Biosimilars industry

  • Comparison between biosimilars and generic small molecules
  • Factors influencing biologics and biosimilars
  • Biosimilars: business and pricing strategy
  • Factors affecting the uptake of biosimilars
  • Biosimilar opportunities
  • Growth of biosimilars 2014– 2020
  • Market penetration of originators and biosimilars in different regions
  • Current and future trends in global oncology biosimilars market
  • Challenges for new entrants

PART 07: Global pharmaceutical market

  • Market size and forecast
  • Global biosimilars market

PART 08: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 09: Market segmentation by end-user

  • Hospitals
  • Retail pharmacies

PART 10: Market segmentation by application

  • Cancer treatment drugs
  • Supportive care drugs

PART 11: Geographical segmentation

  • Global oncology biosimilar drugs market by geographical segmentation 2015-2020
  • Oncology biosimilars market in EMEA
  • Oncology biosimilars market in APAC
  • Oncology biosimilars market in Americas

PART 12: Key leading regions

  • US
  • Europe
  • Japan
  • India
  • China

PART 13: Market drivers

  • Rise in number of patent expiries
  • Increase in prevalence of cancer
  • Growing aging population
  • Promising drug pipeline
  • Need for cost-effective treatment
  • Favorable government regulations

PART 14: Impact of drivers

PART 15: Market challenges

  • Risks related to failure of drugs in market
  • Multiple manufacturing complexities
  • Reluctance among physicians to prescribe biosimilar products
  • Complicated regulatory process
  • Limited availability of biosimilar products
  • Risk of side effects

PART 16: Impact of drivers and challenges

PART 17: Market trends

  • Emergence of biosimilars
  • Outsourcing of biosimilar manufacturing activities
  • Rising number of strategic collaborations
  • Increase in cancer awareness
  • Rise in R&D

PART 18: Vendor landscape

  • Competitive scenario
  • Biocon
  • Celltrion
  • Dr. Reddy's Laboratories
  • F Hoffmann-La Roche
  • Hospira
  • Mylan
  • Sandoz
  • Other prominent vendors

PART 19: Appendix

  • List of abbreviations

PART 20: Explore Technavio

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.


Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases


Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts



  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis


  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your sample now!
  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?
  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis

Certified ISO 9001 : 2015

We are ISO recognized

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Safe and Secure SSL Encrypted

  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Customized Report as per your Business Needs

  • Our analysts will work directly with you and understand your needs
  • Get data on specified regions or segments, competitor and Vendors
  • Data will be formatted and presented as per your requirements
  • We offer $1000 worth of FREE customization at the time of purchase

Let us help you make report more suited to your requirements.

  • Get a competitive breakdown as per your niche industry
  • Customize the data with various metrics that meet your business prerequisite
  • Understand Revenue Sources, Customers and many more
  • Details on Market Share
  • These customizations are done in a short amount of time by our analysts and industry experts
Enquire Before Buying
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>